{"Ticker": "APD", "Company": "Air Products & Chemicals", "Sector": "Materials", "Updated": "2022-02-08", "Rating": {"Date": "2022-02-08", "Rating": "Downgrade", "Organization": "BMO Capital Markets", "Rating_Change": "Outperform to Market Perform", "Target_Change": "$383 to $280"}}
{"Ticker": "CME", "Company": "CME Group", "Sector": "Financials", "Updated": "2022-02-08", "Rating": {"Date": "2022-02-08", "Rating": "Downgrade", "Organization": "Atlantic Equities", "Rating_Change": "Overweight to Neutral", "Target_Change": "$250"}}
{"Ticker": "GM", "Company": "General Motors", "Sector": "Consumer Discretionary", "Updated": "2022-02-08", "Rating": {"Date": "2022-02-08", "Rating": "Downgrade", "Organization": "Morgan Stanley", "Rating_Change": "Overweight to Equal-Weight", "Target_Change": "$75 to $55"}}
{"Ticker": "HAS", "Company": "Hasbro", "Sector": "Consumer Discretionary", "Updated": "2022-02-08", "Rating": {"Date": "2022-02-08", "Rating": "Reiterated", "Organization": "JP Morgan", "Rating_Change": "Neutral", "Target_Change": "$110 to $99"}}
{"Ticker": "IDXX", "Company": "Idexx Laboratories", "Sector": "Health Care", "Updated": "2022-02-08", "Rating": {"Date": "2022-02-08", "Rating": "Initiated", "Organization": "Atlantic Equities", "Rating_Change": "Overweight", "Target_Change": "$650"}}
{"Ticker": "MKTX", "Company": "MarketAxess", "Sector": "Financials", "Updated": "2022-02-08", "Rating": {"Date": "2022-02-08", "Rating": "Initiated", "Organization": "Atlantic Equities", "Rating_Change": "Neutral", "Target_Change": "$380"}}
{"Ticker": "TSN", "Company": "Tyson Foods", "Sector": "Consumer Staples", "Updated": "2022-02-08", "Rating": {"Date": "2022-02-08", "Rating": "Reiterated", "Organization": "Stephens", "Rating_Change": "Overweight", "Target_Change": "$110 to $115"}}
{"Ticker": "TSN", "Company": "Tyson Foods", "Sector": "Consumer Staples", "Updated": "2022-02-08", "Rating": {"Date": "2022-02-08", "Rating": "Reiterated", "Organization": "JP Morgan", "Rating_Change": "Neutral", "Target_Change": "$88 to $91"}}
{"Ticker": "TSN", "Company": "Tyson Foods", "Sector": "Consumer Staples", "Updated": "2022-02-08", "Rating": {"Date": "2022-02-08", "Rating": "Reiterated", "Organization": "Credit Suisse", "Rating_Change": "Neutral", "Target_Change": "$88 to $100"}}
{"Ticker": "TSN", "Company": "Tyson Foods", "Sector": "Consumer Staples", "Updated": "2022-02-08", "Rating": {"Date": "2022-02-08", "Rating": "Reiterated", "Organization": "BofA Securities", "Rating_Change": "Neutral", "Target_Change": "$90 to $100"}}
{"Ticker": "TSN", "Company": "Tyson Foods", "Sector": "Consumer Staples", "Updated": "2022-02-08", "Rating": {"Date": "2022-02-08", "Rating": "Reiterated", "Organization": "BMO Capital Markets", "Rating_Change": "Outperform", "Target_Change": "$90 to $115"}}
{"Ticker": "ZBH", "Company": "Zimmer Biomet", "Sector": "Health Care", "Updated": "2022-02-08", "Rating": {"Date": "2022-02-08", "Rating": "Reiterated", "Organization": "Wells Fargo", "Rating_Change": "Underweight", "Target_Change": "$124 to $111"}}
{"Ticker": "ZBH", "Company": "Zimmer Biomet", "Sector": "Health Care", "Updated": "2022-02-08", "Rating": {"Date": "2022-02-08", "Rating": "Reiterated", "Organization": "UBS", "Rating_Change": "Neutral", "Target_Change": "$130 to $121"}}
{"Ticker": "ZBH", "Company": "Zimmer Biomet", "Sector": "Health Care", "Updated": "2022-02-08", "Rating": {"Date": "2022-02-08", "Rating": "Reiterated", "Organization": "Truist", "Rating_Change": "Buy", "Target_Change": "$145 to $128"}}
{"Ticker": "ZBH", "Company": "Zimmer Biomet", "Sector": "Health Care", "Updated": "2022-02-08", "Rating": {"Date": "2022-02-08", "Rating": "Reiterated", "Organization": "Stifel", "Rating_Change": "Buy", "Target_Change": "$178 to $130"}}
{"Ticker": "ZBH", "Company": "Zimmer Biomet", "Sector": "Health Care", "Updated": "2022-02-08", "Rating": {"Date": "2022-02-08", "Rating": "Reiterated", "Organization": "RBC Capital Mkts", "Rating_Change": "Sector Perform", "Target_Change": "$140 to $125"}}
{"Ticker": "ZBH", "Company": "Zimmer Biomet", "Sector": "Health Care", "Updated": "2022-02-08", "Rating": {"Date": "2022-02-08", "Rating": "Reiterated", "Organization": "JP Morgan", "Rating_Change": "Neutral", "Target_Change": "$150 to $114"}}
{"Ticker": "ZBH", "Company": "Zimmer Biomet", "Sector": "Health Care", "Updated": "2022-02-08", "Rating": {"Date": "2022-02-08", "Rating": "Reiterated", "Organization": "JMP Securities", "Rating_Change": "Mkt Outperform", "Target_Change": "$175 to $145"}}
{"Ticker": "ZBH", "Company": "Zimmer Biomet", "Sector": "Health Care", "Updated": "2022-02-08", "Rating": {"Date": "2022-02-08", "Rating": "Reiterated", "Organization": "Deutsche Bank", "Rating_Change": "Hold", "Target_Change": "$140 to $121"}}
{"Ticker": "ZBH", "Company": "Zimmer Biomet", "Sector": "Health Care", "Updated": "2022-02-08", "Rating": {"Date": "2022-02-08", "Rating": "Reiterated", "Organization": "Citigroup", "Rating_Change": "Buy", "Target_Change": "$150 to $129"}}
{"Ticker": "ZBH", "Company": "Zimmer Biomet", "Sector": "Health Care", "Updated": "2022-02-08", "Rating": {"Date": "2022-02-08", "Rating": "Downgrade", "Organization": "Canaccord Genuity", "Rating_Change": "Buy to Hold", "Target_Change": "$165 to $125"}}
